21 reports

HENCE, IT BECOMES NECESSARY TO REPLACE DEFECTIVE HEARTS WITH MECHANICAL PROSTHESES.

  • Heart Failure
  • World
  • Market Size
  • Abiomed, Inc.
  • Medtronic, Inc.
  • SAPIEN 3 HEART VALVE - HEART FAILURE - PRODUCT STATUS

The ACURATE family of valve products is one of two valve systems in the Boston Scientific structural heart portfolio.

  • Heart Failure
  • Prosthesis
  • United States
  • Edwards Lifesciences Corporation
  • Valtech Cardio, Ltd.
  • By Implant Type

SOUTH AFRICA IS ONE OF THE EMERGING ECONOMIES IN THE WORLD.

  • Heart Failure
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Abiomed, Inc.

The hospital sometimes receives more than one APC reimbursement if more than one CPT code is recorded for each patient.

  • Heart Failure
  • Interventional Cardiology Device
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation
  • BIOQ INTRAAORTIC COUNTERPULSATION PROSTHESIS - PRODUCT DESCRIPTION
  • Application

One unit refers to one total artificial heart.

  • Clinical Trial
  • Heart Failure
  • Prosthesis
  • United States
  • Impella CardioSystems AG

One external remote patient monitoring device consists of one external module or transmitter.

  • Clinical Trial
  • Heart Failure
  • Pharmaceutical
  • United States
  • Pfizer Inc.

One external remote patient monitoring device consists of one external module or transmitter.

  • Cardiovascular Disease
  • Clinical Trial
  • Heart Failure
  • United States
  • Pfizer Inc.

Its product portfolio includes occlusion devices, prosthetic heart valves, pacemakers, cardiac in vitro diagnosis products, angiographic equipment, and anesthetic products.

  • Heart Failure
  • North America
  • United States
  • Forecast
  • Boston Scientific Corporation

It will allow manufacturing on a larger scale with a higher yield to meet prosthesis requirements during the entire PIVOTAL phase and beyond.

  • Assisted Living
  • Clinical Trial
  • Heart Failure
  • United States
  • Impella CardioSystems AG

Interest on notes will be paid on April ## and October ##, commencing October ##, 2017.

  • Heart Failure
  • Medical Device
  • Medical Equipment
  • M&A
  • Medtronic, Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## United Kingdom Source: Glob

  • Acute Coronary Syndrome
  • Cardiovascular Disease
  • Clinical Trial
  • Heart Failure
  • AstraZeneca PLC

KG, is a medical device company that manufactures and distributes prosthetic and orthotic devices.

  • Clinical Trial
  • Heart Failure
  • Pathology
  • Therapy
  • LivaNova PLC
  • VERICIGUAT - DRUG PROFILE

## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Discovery ## ## Total ## ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR CORONARY ARTERY DISEAS

  • Blood Disease
  • Heart Failure
  • United States
  • Company
  • Product Initiative
  • VERICIGUAT - DRUG PROFILE

PATIENTS WERE RANDOMIZED ##:##:## TO EMPA ## MG.

  • Heart Failure
  • Regenerative Medicine
  • North America
  • United States
  • Company

One unit refers to one single chamber pacemaker.

  • Cardiac Management
  • Clinical Trial
  • Heart Failure
  • Medical Device
  • Medtronic, Inc.

One unit refers to one covered stent.

  • Cardiovascular Disease
  • Clinical Trial
  • Heart Failure
  • Interventional Cardiology Device
  • Medtronic, Inc.
  • VERICIGUAT - DRUG PROFILE

HOFFMANN-LA ROCHE LTD EZRA PHARMA LLC FIBROGEN INC G## PHARMACEUTICALS INC GALENICA LTD GBSCIENCES INC HEMOSTEMIX INC IHEART JAPAN CORP IMMUNWORK INC INTRA-CELLULAR THERAPIES INC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PR ##

  • Cardiovascular Disease
  • Chronic Disease
  • Heart Failure
  • United States
  • Product Initiative

One unit refers to one cardiac resynchronisation therapy - defibrillator.

  • Cardiac Management
  • Heart Failure
  • Magnetic Resonance Imaging
  • Patient Monitoring
  • LivaNova PLC

One unit refers to one cardiac resynchronization therapy - pacemaker.

  • Cardiac Management
  • Clinical Trial
  • Heart Failure
  • Magnetic Resonance Imaging
  • Medtronic, Inc.
  • 5. All the trials included are unique trials.

## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## Canada ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## United Kingdom Source

  • Acute Coronary Syndrome
  • Clinical Trial
  • Heart Failure
  • World
  • AstraZeneca PLC
  • 1.1 Heart Failure

In valve replacement surgery, the damaged valve is replaced by an artificial (prosthetic) valve.

  • Heart Failure
  • United States
  • World
  • Market Size
  • Thoratec Corporation